ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,051.09
      0.00%
      US Tech 100
      21,191.20
      0.62%
      Dow Jones
      43,828.06
      -0.20%
      Brent Oil
      74.135
      0.00%
      Bitcoin
      101,953.02
      0.49%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

      Eupraxia Pharmaceuticals Inc

      Eupraxia Pharmaceuticals Inc (EPRX)

      Eupraxia Pharmaceuticals Inc
      4.85
      0.13
      (2.75%)
      Closed December 14 4:12PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      4.85
      Bid
      4.82
      Ask
      4.85
      Volume
      13,165
      4.73 Day's Range 4.87
      3.07 52 Week Range 7.64
      Market Cap
      132.318M
      Previous Close
      4.72
      Open
      4.73
      Last Trade
      27
      @
      4.85
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      30,336
      Shares Outstanding
      27,282,000
      Dividend Yield
      -
      PE Ratio
      -4.69
      Earnings Per Share (EPS)
      -1.03
      Revenue
      -
      Net Profit
      -28.22M

      About Eupraxia Pharmaceuticals Inc

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.eupraxiapharma.com
      Headquarters
      Victoria, British Columbia, Can
      Founded
      -
      Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $4.72. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3.07 to $ 7.64.

      Eupraxia Pharmaceuticals currently has 27,282,000 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $128.77 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.69.

      Ask ADVFN Intelligence (AI)

      EPRX Latest News

      More News

      Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

      Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months Canada NewsWire VICTORIA, BC, Nov. 20, 2024...

      November 20 2024
      PR Newswire (Canada)

      Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

      Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting Canada NewsWire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /CNW/ - Eupraxia...

      November 14 2024
      PR Newswire (Canada)

      Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

      Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

      November 13 2024
      PR Newswire (Canada)

      Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

      Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

      November 12 2024
      PR Newswire (Canada)

      Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results

      Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...

      November 07 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.368.017817371944.494.874.4171984.64334667CS
      40.5613.05361305364.295.454.1223724.77240499CS
      120.9524.3589743593.95.453.07303364.18870627CS
      261.2434.34903047093.615.453.07231853.93775121CS
      52-0.66-11.97822141565.517.643.07329664.3382798CS
      1562.97157.9787234041.889.10.8275264.27034799CS
      260-2.9-37.41935483877.759.10.8250544.22950177CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RTGRTG Mining Inc
      $ 0.03
      (20.00%)
      		16.86k
      GMTNGold Mountain Mining Corp
      $ 0.035
      (16.67%)
      		33k
      HBPHelix BioPharma Corp
      $ 1.00
      (14.94%)
      		25.07k
      YRBYorbeau Resources Inc
      $ 0.04
      (14.29%)
      		988k
      AIDXHealWell AI Inc
      $ 2.32
      (12.62%)
      		2.86M
      BNGBengal Energy Ltd
      $ 0.01
      (-33.33%)
      		15.33k
      SCYScandium International Mining Corp
      $ 0.015
      (-25.00%)
      		7k
      FLNTFlint Corporation
      $ 0.025
      (-16.67%)
      		48k
      NCFNorthcliff Resources Ltd
      $ 0.025
      (-16.67%)
      		26.56k
      DIAMStar Diamond Corporation
      $ 0.025
      (-16.67%)
      		554.79k
      CNQCanadian Natural Resources Ltd
      $ 44.79
      (-0.51%)
      		24.88M
      PPLPembina Pipeline Corporation
      $ 54.61
      (-0.60%)
      		9M
      TRPTC Energy Corporation
      $ 66.12
      (-0.62%)
      		5.23M
      MFCManulife Financial Corporation
      $ 44.05
      (0.46%)
      		5.2M
      TDToronto Dominion Bank
      $ 75.86
      (-0.30%)
      		4.99M

      Discussion

      View Full Feed
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
      A lot of shares were cancelled
      ZHUD
      TRUSTUNITS1000000 TRUSTUNITS1000000 2 minutes ago
      Hit 0.03 according to chart
      ZHUD
      TRUSTUNITS1000000 TRUSTUNITS1000000 4 minutes ago
      Interesting company
      ZHUD
      TRUSTUNITS1000000 TRUSTUNITS1000000 5 minutes ago
      INDR
      INDR
      lakers17 lakers17 7 minutes ago
      I sure hope for shareholder's sake that Tilton is not drinking or on drugs. I have never seen such obsessive Tweeting, one Tweet after another. (actually on X it's supposed to be called posts but Tweets sound better) Totally obsessive. Garbage Tweet after garbage Tweet today and December 10th. A
      NSAV
      TRUSTUNITS1000000 TRUSTUNITS1000000 8 minutes ago
      EEENF
      EEENF
      Rader1977 Rader1977 11 minutes ago
      COA #2: Buy options now at $.10.

      Any significant news that would drive NB share price up bigly would theoretically also drive up the warrant price significantly.

      Sell options when they hit $1.00.

      This would be a x10 ROI.

      Could
      NB
      hssbwwmp hssbwwmp 11 minutes ago
      What is the timeframe for your deja-vu $.02-.10 targets?
      AXXA
      Adam917 Adam917 11 minutes ago
      Yes, but if Alex doesn't fix yield sign soon enough, volume (whatever there is now) will dry up. Yield sign will keep new investors away.
      UATG
      CrimsonNightRider CrimsonNightRider 13 minutes ago
      Bro how much they pay you to regurgitate their press releases?

      https://investorshub.advfn.com/uimage/uploads/2024/8/11/vbdpc84327BBA-2382-42F7-A6E9-E298E7D668B6.gif
      IQST
      RKT989 RKT989 18 minutes ago
      @wow, you are one upset and negative person...The pot calling the kettle Aye
      ERHE
      Dapper1 Dapper1 19 minutes ago
      You sound like a shorty parasite!
      HMBL
      Kyle279 Kyle279 25 minutes ago
      So ... do you have a way of determining the timing of the RS strategically BEFORE it happens?   Do tell.   
      HMBL
      gdog gdog 26 minutes ago
      good grief
      NLST
      ty3 ty3 26 minutes ago
      A couple more months, might be a billionaire ?
      DJT
      Canna_Business Canna_Business 33 minutes ago
      $IONQ $RKLB $MRMD $T $MSFT $BICEY $LNVGY $JEPI $UVXY $SQQ $ES_F
      BICEY IONQ JEPI
      Canna_Business Canna_Business 33 minutes ago
      $IONQ $RKLB $MRMD $T $MSFT $BICEY $LNVGY $JEPI $UVXY $SQQ $ES_F
      BICEY IONQ JEPI
      Canna_Business Canna_Business 33 minutes ago
      $IONQ $RKLB $MRMD $T $MSFT $BICEY $LNVGY $JEPI $UVXY $SQQ $ES_F
      BICEY IONQ JEPI
      DKLN DKLN 41 minutes ago
      We have discussed that this "company" has zippo substantive accomplishments for investors in 5+ years (or since the beginning). We have also discussed that this "company" has released 11 straight quarterly reports with zippo revenue. Keep watching the triple zero PPS and horrible volume day after da
      MCIC
      Steady_T Steady_T 41 minutes ago
      Validation is the first step in the process. That is where they verify that all the required parts of the submittal are there and in the right format.

      That is not the approval stage of the process. It is the evaluation of the MAA that takes the long time and hopefully results in appr
      NWBO
      lakers17 lakers17 42 minutes ago
      Hilarious Tweets. They have no money and what are they on their 4th lawyer and never paid in full the others. How about filing or they are on the expert market. Here starts the nonsense comedy Tweeting: (Wow life changing for shareholders) Let the fools here buy high priced shares. This is bett
      NSAV
      PonderosaPack PonderosaPack 46 minutes ago
      Doc - you speaking greek to me a lot. I wanna get your opinion - since every time you speak its in these technical terms. You are in it. I love this stuff - but Honestly I don't get all what you are saying. can you fly up 30,000 feet and tell me your thoughts about IONQ? I would appreciat
      IONQ
      familyof5 familyof5 46 minutes ago
      "HMBL was faced with some terrible choices in financing and decided to take on toxic debt"

      Was there a mismanagement of funds during that phase of the HMBL stock BOOM? If my memory servers me correct HMBL stock was trading well over 1.00 during Luna's on boarding. So HMBL went from th
      HMBL
      igotthemojo igotthemojo 48 minutes ago
      "All successful companies compensate the board and executives nicely."

      are you implying that a company who is laying off employees by the hundreds, cant turn a profit, and went from $29 to 32 cents can be called successful?......in what world?...
      FCEL

      Your Recent History

      TSX
      EPRX
      Eupraxia Pharmaceuticals
      Delayed Upgrade Clock